Profile: Spiration, Inc. focuses on improving the quality of life of patients with acute and chronic conditions of the lung through the development of novel therapies. We develop IBV® valve system, which offers a minimally invasive treatment for patients with emphysema. Our IBV® valve system improves disease-related health status of people living with emphysema. Our IBV valve comprises of nitnol frame and a polymer membrane which is held against the airway mucosa by six elastic struts that can expand and contract with airway movement during breathing.

FDA Registration Number: 3004450998